Related Experiment Video
Updated: Aug 9, 2026

Ex Vivo Intestinal Sacs to Assess Mucosal Permeability in Models of Gastrointestinal Disease
Published on: February 9, 2016
The healing of gastric ulcers by zinc sulphate
Abstract:
A double-blind trial of zinc sulphate given by mouth (220 mg, three times a day) and placebo was undertaken in patients with benign gastric ulcers. The drug was given for a three-week period and the healing of the ulcers was estimated from results of barium-meal X-ray films taken immediately before and after this period. There were ten patients taking zinc sulphate and eight patients taking placebo. The two groups of patients were comparable in all respects, including initial ulcer size. Patients taking zinc sulphate had an ulcer healing rate three times that of patients treated with placebo. This difference was significant (P less than 0-05). Complete healing of ulcers occurred more frequently in the patients taking zinc sulphate than in patients treated with placebo. The placebo group contained more patients whose ulcers did not heal at all, than the group taking zinc sulphate. No side effects from zinc sulphate were noted. There was no evidence of zinc deficiency in any of the patients.
Related Concept Videos
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds to M3...
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...

